| β-Blocker treatment during pregnancy and adverse pregnancy outcomes: a nationwide population-based cohort study KM Petersen, E Jimenez-Solem, JT Andersen, M Petersen, K Brødbæk, ... Bmj Open 2 (4), e001185, 2012 | 175 | 2012 |
| Exposure to selective serotonin reuptake inhibitors and the risk of congenital malformations: a nationwide cohort study E Jimenez-Solem, JT Andersen, M Petersen, K Broedbaek, JK Jensen, ... BMJ open 2 (3), e001148, 2012 | 160 | 2012 |
| Prevalence of antidepressant use during pregnancy in Denmark, a nation-wide cohort study E Jimenez-Solem, JT Andersen, M Petersen, K Broedbaek, NL Andersen, ... PloS one 8 (4), e63034, 2013 | 147 | 2013 |
| Dulaglutide, a long-acting GLP-1 analog fused with an Fc antibody fragment for the potential treatment of type 2 diabetes E Jimenez-Solem, MH Rasmussen, M Christensen, FK Knop Curr Opin Mol Ther 12 (6), 790-7, 2010 | 130 | 2010 |
| Urinary markers of nucleic acid oxidation and long-term mortality of newly diagnosed type 2 diabetic patients K Broedbaek, V Siersma, T Henriksen, A Weimann, M Petersen, ... Diabetes care 34 (12), 2594-2596, 2011 | 123 | 2011 |
| Exposure to selective serotonin reuptake inhibitors in early pregnancy and the risk of miscarriage JT Andersen, NL Andersen, H Horwitz, HE Poulsen, E Jimenez-Solem Obstetrics & Gynecology 124 (4), 655-661, 2014 | 97 | 2014 |
| Developing and validating COVID-19 adverse outcome risk prediction models from a bi-national European cohort of 5594 patients E Jimenez-Solem, TS Petersen, C Hansen, C Hansen, C Lioma, C Igel, ... Scientific reports 11 (1), 3246, 2021 | 90 | 2021 |
| Association between urinary markers of nucleic acid oxidation and mortality in type 2 diabetes: a population-based cohort study K Broedbaek, V Siersma, T Henriksen, A Weimann, M Petersen, ... Diabetes care 36 (3), 669-676, 2013 | 90 | 2013 |
| Shift from adalimumab originator to biosimilars in Denmark TB Jensen, SC Kim, E Jimenez-Solem, D Bartels, HR Christensen, ... JAMA internal medicine 180 (6), 902-903, 2020 | 82 | 2020 |
| Combinations of polymorphisms in genes involved in the 5-Fluorouracil metabolism pathway are associated with gastrointestinal toxicity in chemotherapy-treated colorectal cancer … S Afzal, M Gusella, B Vainer, UB Vogel, JT Andersen, K Broedbaek, ... Clinical Cancer Research 17 (11), 3822-3829, 2011 | 80 | 2011 |
| SSRI use during pregnancy and risk of stillbirth and neonatal mortality E Jimenez-Solem, JT Andersen, M Petersen, K Broedbaek, AR Lander, ... American Journal of Psychiatry 170 (3), 299-304, 2013 | 69 | 2013 |
| Clarithromycin in early pregnancy and the risk of miscarriage and malformation: a register based nationwide cohort study JT Andersen, M Petersen, E Jimenez-Solem, K Broedbaek, NL Andersen, ... PLOS one 8 (1), e53327, 2013 | 68 | 2013 |
| The use and safety of TNF inhibitors during pregnancy in women with psoriasis: a review CB Johansen, E Jimenez-Solem, A Haerskjold, FL Sand, SF Thomsen International journal of molecular sciences 19 (5), 1349, 2018 | 57 | 2018 |
| Long term treatment with stimulant laxatives–clinical evidence for effectiveness and safety? M Noergaard, J Traerup Andersen, E Jimenez-Solem, ... Scandinavian Journal of Gastroenterology 54 (1), 27-34, 2019 | 53 | 2019 |
| The association of polymorphisms in 5-fluorouracil metabolism genes with outcome in adjuvant treatment of colorectal cancer S Afzal, M Gusella, SA Jensen, B Vainer, U Vogel, JT Andersen, ... Pharmacogenomics 12 (9), 1257-1267, 2011 | 52 | 2011 |
| Risk of adverse pregnancy outcome after paternal exposure to methotrexate within 90 days before pregnancy LK Eck, TB Jensen, D Mastrogiannis, A Torp-Pedersen, B Askaa, ... Obstetrics & Gynecology 129 (4), 707-714, 2017 | 45 | 2017 |
| GLP-1 based therapies and disease course of inflammatory bowel disease M Villumsen, AB Schelde, E Jimenez-Solem, T Jess, KH Allin EClinicalMedicine 37, 2021 | 40 | 2021 |
| Use of tramadol and other analgesics following media attention and risk minimization actions from regulators: a Danish nationwide drug utilization study AMS Sørensen, L Rasmussen, MT Ernst, SH Mogensen, MV Laursen, ... European Journal of Clinical Pharmacology 77, 617-624, 2021 | 36 | 2021 |
| Urinary markers of nucleic acid oxidation and cancer in type 2 diabetes K Broedbaek, V Siersma, T Henriksen, A Weimann, M Petersen, ... Redox Biology 4, 34-39, 2015 | 36 | 2015 |
| Ondansetron use in early pregnancy and the risk of congenital malformations-a register based nationwide cohort study JT Andersen, E Jimenez-Solem, NL Andersen, HE Poulsen Pharmacoepidemiol Drug Saf 22, 13-4, 2013 | 36 | 2013 |
Jon Trærup Andersen, MD, PhDUniversity of Copenhagen and Copenhagen University Hospital BispebjergVerified email at traerup.dk